$0
0
0.00%
$4.32
Baillie Gifford started to build up the position in Sangamo Therapeutics in Q2 2022. Since then they sold 2.51 Thousand shares. The investor sold all their shares in Q2 2023 and doesn't own any shares in Sangamo Therapeutics anymore.
Easily embed the chart on your blog or website – it will always update automatically!